Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
iRhythm Technologies Inc(IRTC)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for IRTC
11/13/2026: IRTC (1-star) is currently NOT-A-BUY. Pass it for now.
iRhythm Technologies is a prominent medical technology firm known for its Zio wearable cardiac monitoring devices and AI-powered diagnostic software. The company has a leading position in the transition from traditional, short-term heart monitoring to long-term, continuous wearable solutions. Its primary growth opportunity lies in further clinical adoption and international market expansion, supported by a significant proprietary dataset. However, the investment is subject to substantial risks, including reliance on fluctuating insurance reimbursement rates and intense competition from large medical device manufacturers. The stock may best suit growth-oriented investors with a high risk tolerance who are monitoring reimbursement trends and clinical service adoption rates.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The company is a primary player in the adoption of digital diagnostic tools, offering high revenue growth potential. |
| Momentum investor | Mixed fit | The stock often experiences periods of high volatility linked to reimbursement news and growth execution. |
| Value investor | Weak fit | The company is currently prioritizing growth and market scale over current earnings and dividends. |
| Dividend investor | Weak fit | iRhythm does not pay a dividend and focuses capital on R&D and expansion. |
| Low-risk investor | Weak fit | High regulatory and competitive risks make this a high-volatility investment. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock reacts sharply to regulatory updates and shifts in healthcare policy. |
| Valuation risk | Medium / high | Growth expectations are already priced into the stock, leaving little margin for error. |
| Competition risk (AI and digital health) | Medium / high | Large incumbents and new tech entrants are aggressively pursuing cardiac monitoring market share. |
| Business quality | Medium | The company provides a critical service, but faces ongoing challenges in achieving sustained profitability. |
| Dividend income | Low / none | No income is returned to shareholders. |
| Execution risk | Medium | Successful international scaling and maintaining reimbursement are required for long-term success. |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 3.01B USD | Price to earnings Ratio - | 1Y Target Price 155.64 |
Price to earnings Ratio - | 1Y Target Price 155.64 | ||
Volume (30-day avg) 830.4K shares | Beta 1.47 | 52 Weeks Range 82.85 - 192.47 | Updated Date 11/13/2026 |
52 Weeks Range 82.85 - 192.47 | Updated Date 11/13/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.17 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 62.6%
- Active BUY / eligible
- 72 / 115
- 30-Day BUY Count Change
- +35
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Medical Devices
- BUY participation
- 62.5%
- Active BUY / eligible
- 5 / 8
- 30-Day BUY Count Change
- +3
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior
Downtrend
The stock has experienced a sustained decline in price over recent periods.
Extreme Price Shocks
The stock has experienced exceptionally large and disruptive price movements during the period.
Analysis of Past Performance
Type Stock | Historic Profit -29.99% | Avg. Invested days 33 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 11/13/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Cardiac Monitoring Services | Revenue from Zio patch service, including device shipping, data analysis, and physician reporting. | The company generates revenue every time a doctor orders a Zio service for a patient. |
| Geography | Primary revenue is from the United States; international expansion is in early stages. | Growth is currently tied to U.S. clinical adoption, with future upside dependent on international market entry. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2026-11-05 | When After Market | Estimate 0.02 | Actual 0.82 |
Profitability
Profit Margin -4.52% | Operating Margin (TTM) 4.51% |
Management Effectiveness
Return on Assets (TTM) 2.31% | Return on Equity (TTM) -25.81% |
Valuation
Trailing PE - | Forward PE 55.56 | Enterprise Value 3.32B | Price to Sales(TTM) 3.53 |
Enterprise Value 3.32B | Price to Sales(TTM) 3.53 | ||
Enterprise Value to Revenue 3.88 | Enterprise Value to EBITDA 1340.53 | Shares Outstanding 33.19M | Shares Floating 30.94M |
Shares Outstanding 33.19M | Shares Floating 30.94M | ||
Percent Insiders 1.15 | Percent Institutions 106.7 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.